In decidedly threatening language, Braverman would inadvertently help to goad Sherman toward some key decisions. Ultimately, the recommendations here emerge there from. Specifically, in his threatening language, Braverman reveals that Promedico is decidedly weakened by Glaxo's threat at a hostile takeover. The discomfort between Wellcome and Promedico has reached a fever pitch and it is incumbent upon Sherman to take all necessary steps to help facilitate a handover to Glaxo. Indeed, the move from Promedico to greener pastures had seemed an inevitability for some time given the degree to which Wellcome both routinely outperformed its counterparts in the company and seemed culturally to be a poor fit with other segments of Promedico. With Glaxo now in the picture, Sherman should seize the opportunity to exercise some degree of...

This will mean establishing direct contact with her likely future superiors at Glaxo and becoming an active part in the change over. In particular, and in possible, it might be appealing simply to bring her team over to Glaxo. In most regards, the already autonomous and modestly sized group could be easily transplanted to a new company with little operational interruption. Moreover, a top priority for Sherman must be to protect her personnel and her own position during the transformation. By taking an active role in this process, Sherman can ensure that she and her team are indispensable while simultaneously strengthening the likelihood of Glaxo's eventual takeover. Ultimately, for Sherman and her team, this new parent company should only help to improve flexibility and reach within a growing marketplace.